Device Trial Radar · NCT05907564
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
120
Actual
Start
Sep 20, 2023
Primary completion
Feb 20, 2025
Study completion Feb 2027
Sponsor
- Lead sponsor
- Inquis Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.
Conditions
- Pulmonary Embolism
- Embolism
- Embolism and Thrombosis
- Vascular Diseases
- Cardiovascular Diseases
- Lung Diseases
- Respiratory Tract Diseases
Interventions
ThrombectomyDevice
Use of Aventus Thrombectomy System to treat pulmonary embolism
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in RV/LV RatioTime frame: at 48hrs compared to baseline
1 more outcomes with a free account
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Honor Health
Scottsdale, Arizona
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.